LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

Search

Smith & Nephew PLC ADR

Gesloten

32.93 -1.23

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.87

Max

33.51

Belangrijke statistieken

By Trading Economics

Inkomsten

35M

331M

Verkoop

203M

3.2B

K/W

Sectorgemiddelde

23.14

57.833

Dividendrendement

2.36

Winstmarge

10.368

Werknemers

17,000

EBITDA

133M

856M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+4.76% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.36%

2.47%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.1B

14B

Vorige openingsprijs

34.16

Vorige sluitingsprijs

32.93

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Smith & Nephew PLC ADR Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 mrt 2026, 22:51 UTC

Winsten

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 mrt 2026, 21:40 UTC

Acquisities, Fusies, Overnames

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 mrt 2026, 20:31 UTC

Winsten

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 mrt 2026, 23:49 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 mrt 2026, 23:31 UTC

Marktinformatie

Gold Rises on Likely Technical Recovery -- Market Talk

18 mrt 2026, 22:49 UTC

Marktinformatie

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 mrt 2026, 22:41 UTC

Marktinformatie

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 mrt 2026, 22:36 UTC

Winsten

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 mrt 2026, 22:24 UTC

Winsten

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 mrt 2026, 22:23 UTC

Winsten

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 mrt 2026, 22:23 UTC

Winsten

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 mrt 2026, 21:58 UTC

Winsten

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 mrt 2026, 21:55 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

18 mrt 2026, 21:55 UTC

Marktinformatie
Winsten

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 mrt 2026, 21:40 UTC

Marktinformatie

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 mrt 2026, 21:16 UTC

Marktinformatie

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 mrt 2026, 21:00 UTC

Belangrijke Nieuwsgebeurtenissen

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 mrt 2026, 20:58 UTC

Winsten

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 mrt 2026, 20:41 UTC

Winsten

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mrt 2026, 20:29 UTC

Winsten

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mrt 2026, 20:25 UTC

Winsten

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mrt 2026, 20:17 UTC

Winsten

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 mrt 2026, 20:14 UTC

Marktinformatie

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 mrt 2026, 20:09 UTC

Winsten

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 mrt 2026, 20:07 UTC

Winsten

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 mrt 2026, 20:06 UTC

Winsten

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 mrt 2026, 20:04 UTC

Winsten

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 mrt 2026, 20:04 UTC

Winsten

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 mrt 2026, 20:04 UTC

Winsten

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 mrt 2026, 20:03 UTC

Winsten

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Peer Vergelijking

Prijswijziging

Smith & Nephew PLC ADR Prognose

Koersdoel

By TipRanks

4.76% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 34.96 USD  4.76%

Hoogste 35 USD

Laagste 34.91 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Smith & Nephew PLC ADR - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

0

Buy

2

Hold

0

Sell

Technische score

By Trading Central

26.64 / 28.37Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Bullish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat